Avalon Villa Care Center discontinued behavior tracking for Resident 2 on October 14 without replacing the monitoring order, even though the patient remained on daily Depakote prescribed specifically for "mood disorder manifested by angry outbursts," according to inspection records.
The resident's diagnoses included schizoaffective disorder, schizophrenia, and depression. Medical records showed the patient experienced hallucinations and took anticonvulsant medication for behavioral conditions.
For five months, from May through October, nursing staff had monitored and documented the frequency of Resident 2's angry outbursts every shift. The tracking system allowed the healthcare team to determine whether the 500-milligram daily Depakote dose needed adjustment.
"Monitoring and documenting Resident 2's behaviors allowed the healthcare team to determine the efficacy of Depakote and whether the medication dose had to be increased or decreased," Registered Nurse 2 told inspectors on December 23.
But that systematic observation ended abruptly. RN 2 confirmed the behavior monitoring "was discontinued on 10/14/2025 and was never reordered."
The lapse continued for more than two months. When inspectors arrived in December, Resident 2 was still receiving the psychiatric medication without any formal tracking of the behaviors it was meant to control.
Medical records painted a complex picture of the resident's condition. The patient's cognition remained intact according to November assessments, and they functioned independently with eating, personal hygiene, and dressing. However, a May medical evaluation noted the resident "did not have the capacity to understand and make decisions."
The care plan specifically called for monitoring "behavior episodes of mood disorder manifested by angry outbursts every shift" and documenting their frequency. This wasn't optional monitoring — it was a required intervention outlined in the resident's individualized care plan from June.
RN 2 explained how the system was supposed to work. Licensed nurses used a Behavior Monitoring Sheet to tally the frequency of behaviors each shift. This data informed medical decisions about whether to continue, increase, or decrease the Depakote dosage.
Without that tracking, medical staff operated blind.
"Without proper monitoring, Resident 2 may experience more behaviors that are improperly managed," RN 2 acknowledged to inspectors.
The facility's own policies required this type of monitoring. Avalon Villa's Antipsychotic Medication Use policy, revised in July 2022, stated: "The staff will observe, document, and report to the attending physician information regarding the effectiveness of any interventions, including antipsychotic medications."
The policy wasn't being followed.
Depakote, the medication Resident 2 continued receiving, is an anticonvulsant commonly used to treat mood disorders and control aggressive behaviors in psychiatric patients. Proper dosing requires ongoing assessment of its effectiveness through behavioral observation.
The inspection occurred following a complaint, suggesting someone raised concerns about care quality at the facility. Federal investigators classified the violation as having "minimal harm or potential for actual harm" affecting "few" residents.
But for Resident 2, the consequences of unmeasured medication could be significant. Too little medication might allow dangerous behaviors to escalate. Too much could cause unnecessary sedation or other side effects.
The resident had already experienced multiple admissions to the facility, according to records. Proper medication management could be critical to preventing future psychiatric crises requiring hospitalization.
RN 2's comments suggested staff understood the importance of behavior monitoring. The nurse clearly articulated how tracking data informed treatment decisions and warned about the risks of inadequate monitoring.
Yet the monitoring simply stopped. No explanation appears in the inspection report for why the October 14 discontinuation occurred or why replacement orders weren't written.
The facility failed to ensure one of its most vulnerable residents received appropriate psychiatric care monitoring. Resident 2 continued taking powerful medication for angry outbursts while staff stopped watching for the very behaviors the drug was meant to control.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Avalon Villa Care Center from 2025-12-23 including all violations, facility responses, and corrective action plans.